{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T05:26:33Z","timestamp":1669699593594},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Since the introduction of highly active antiretroviral therapy (HAART), acquired immune deficiency syndrome (AIDS) related mortality has markedly declined. As HAART is becoming increasingly available, the infection with human immunodeficiency virus (HIV+) in sub-Saharan Africa (SSA) is becoming a chronic condition. While pregnancy in HIV+ women in SSA has always been considered a challenging event for the mother and the fetus, for pregnant HIV+ women also diagnosed with epilepsy (WWE), there are additional risks as HIV increases the odds of developing seizures due to the vulnerability of the central nervous system to other infections, immune dysfunction, and overall metabolic disturbances. In light of a growing proportion of HIV+ WWE on HAART and an increasing number of pregnant women accessing mother-to-child transmission of HIV programs through provision of HAART in SSA, there is a need to develop contextualized and evidenced-based clinical strategies for the management of epilepsy in this population. In this study, we conduct a literature scoping review to identify issues that warrant consideration for clinical management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>Twenty-three articles were retained after screening, which covered six overarching clinical aspects: status epilepticus (SE), Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN), dyslipidemia, congenital malformation (CM), chronic kidney disease (CKD), and neurological development. No studies for our population of interest were identified, highlighting the need for a cautionary approach to be employed when extrapolating findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>High risks of CM and drug interactions with first-line antiepileptic drugs (AEDs) warrant measures to increase the accessibility and choices of safer second-line AEDs. To ensure evidence-based management of epilepsy within this population, the potential high prevalence of SE, CKD, dyslipidemia, and SJS\/TEN and the cumulative effect of drug-drug interactions should be considered. Further understanding of the intersections between pregnancy and drug-drug interactions in SSA is needed to ensure evidenced-based management of epilepsy in pregnant HIV+ WWE. To prevent SE, the barriers for AED treatment adherence in pregnant HIV+ women should be explored. Our review underscores the need to conduct cohort studies of HIV+ WWE in reproductive age over time and across pregnancies to capture the cumulative effect of HAART and AED to inform clinical management.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12916-020-01799-0","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T02:02:25Z","timestamp":1605578545000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epilepsy management in pregnant HIV+ women in sub-Saharan Africa, clinical aspects to consider: a scoping review"],"prefix":"10.1186","volume":"18","author":[{"given":"Sonia","family":"Menon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Benova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Mabeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"1799_CR1","unstructured":"World Health Organization, Geneva, Switzerland (2020); Key facts 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids accessed online on October 2nd 2020."},{"key":"1799_CR2","unstructured":"UNAIDS, Geneva, Switzerland (2020); Global HIV & AIDS statistics 2020 fact sheet. https:\/\/www.unaids.org\/en\/resources\/fact-sheet accessed online on October 2nd 2020."},{"key":"1799_CR3","unstructured":"UNAIDS, Geneva, Switzerland (2019) Fact sheet-World AIDS day https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf 2019 accessed online on October 2nd 2020."},{"key":"1799_CR4","unstructured":"AVERT, United Kingdom (2019) Programming\/prevention\/prevention-mother-child transmission of HIV. https:\/\/www.avert.org\/professionals\/hivprogramming\/prevention\/prevention-mother-child accessed online on October 2nd 2020."},{"issue":"9903","key":"1799_CR5","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet (London, England). 2013;382(9903):1525\u201333.","journal-title":"Lancet (London, England)"},{"key":"1799_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13601-017-0188-1","volume":"8","author":"B Sousa-Pinto","year":"2018","unstructured":"Sousa-Pinto B, et al. Stevens-Johnson syndrome\/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database. Clin Trans Allergy. 2018;8:2\u20132.","journal-title":"Clin Trans Allergy"},{"issue":"1","key":"1799_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/COH.0000000000000023","volume":"9","author":"L Ryom","year":"2014","unstructured":"Ryom L, Mocroft A, Lundgren JD. Antiretroviral therapy, immune suppression and renal impairment in HIV-positive persons. Curr Opin HIV AIDS. 2014;9(1):41\u20137.","journal-title":"Curr Opin HIV AIDS"},{"key":"1799_CR8","doi-asserted-by":"crossref","unstructured":"Islam FM, et al. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012; p. n\/a-n\/a.","DOI":"10.1111\/j.1468-1293.2012.00996.x"},{"issue":"6","key":"1799_CR9","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/ije\/dyt198","volume":"42","author":"DG Dillon","year":"2013","unstructured":"Dillon DG, et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol. 2013;42(6):1754\u201371.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"1799_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11940-013-0237-6","volume":"15","author":"O Siddiqi","year":"2013","unstructured":"Siddiqi O, Birbeck GL. Safe Treatment of Seizures in the Setting of HIV\/AIDS. Curr Treat Options Neurol. 2013;15(4):529\u201343.","journal-title":"Curr Treat Options Neurol"},{"key":"1799_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.yebeh.2019.01.033","volume":"93","author":"P Ssentongo","year":"2019","unstructured":"Ssentongo P. Prevalence and incidence of new-onset seizures and epilepsy in patients with human immunodeficiency virus (HIV): Systematic review and meta-analysis. Epilepsy Behav. 2019;93:49\u201355.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"1799_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","volume":"88","author":"KM Fiest","year":"2017","unstructured":"Fiest KM, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296\u2013303.","journal-title":"Neurology"},{"key":"1799_CR13","volume-title":"Definition of Epilepsy: A perspective for patients and caregivers","author":"Epilepsy, I.L.a","year":"2014","unstructured":"Epilepsy, I.L.a., Definition of Epilepsy: A perspective for patients and caregivers 2014 ( https:\/\/www.ilae.org\/guidelines\/definition-and-classification\/the-2014-definition-of-epilepsy-a-perspective-for-patients-and-caregivers)."},{"issue":"885","key":"1799_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/pgmj.75.885.387","volume":"75","author":"RK Garg","year":"1999","unstructured":"Garg RK. HIV infection and seizures. Postgrad Med J. 1999;75(885):387\u201390.","journal-title":"Postgrad Med J"},{"issue":"3","key":"1799_CR15","first-page":"56","volume":"8","author":"SA Chaudhry","year":"2015","unstructured":"Chaudhry SA, et al. Human Immunodeficiency Viral Infection and Status Epilepticus in United States (2002-2009). J Vasc Interv Neurol. 2015;8(3):56\u201361.","journal-title":"J Vasc Interv Neurol"},{"key":"1799_CR16","unstructured":"World Health Organization (2019) Geneva, Switzerland; Epilepsy, key facts, 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy accessed online on October 2nd 2020."},{"key":"1799_CR17","unstructured":"World Health Organization, Geneva, Switzerland (2019), Epilepsy 2019 https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy accessed online on October 2nd 2020."},{"issue":"4","key":"1799_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2471\/BLT.09.064147","volume":"88","author":"A-C Meyer","year":"2010","unstructured":"Meyer A-C, et al. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ. 2010;88(4):260\u20136.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"1799_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.seizure.2004.11.003","volume":"14","author":"NF Ndoye","year":"2005","unstructured":"Ndoye NF, et al. Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE\/IBE\/WHO study. Seizure. 2005;14(2):106\u201311.","journal-title":"Seizure"},{"issue":"2","key":"1799_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4314\/ahs.v12i2.17","volume":"12","author":"JH Chin","year":"2012","unstructured":"Chin JH. Epilepsy treatment in sub-Saharan Africa: closing the gap. Afr Health Sci. 2012;12(2):186\u201392.","journal-title":"Afr Health Sci"},{"issue":"5","key":"1799_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1528-1167.2005.52704.x","volume":"46","author":"D Chisholm","year":"2005","unstructured":"Chisholm D. Cost-effectiveness of First-line Antiepileptic Drug Treatments in the Developing World: A Population-level Analysis. Epilepsia. 2005;46(5):751\u20139.","journal-title":"Epilepsia"},{"key":"1799_CR22","unstructured":"World Health Organization, Geneva, Switzerland (2018); Update on antiretroviral regimens for treating and preventing HIV infection and update on early infant diagnosis of HIV https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/273129\/WHO-CDS-HIV-18.19-eng.pdf?sequence=1&isAllowed=y accessed online on October 2nd, 2020."},{"issue":"6","key":"1799_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jiac.2017.12.022","volume":"24","author":"S Hikasa","year":"2018","unstructured":"Hikasa S, et al. A potential drug interaction between phenobarbital and dolutegravir: A case report. J Infect Chemother. 2018;24(6):476\u20138.","journal-title":"J Infect Chemother"},{"issue":"3","key":"1799_CR24","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/jac\/dkx461","volume":"73","author":"A Palazzo","year":"2017","unstructured":"Palazzo A, et al. Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid. J Antimicrob Chemother. 2017;73(3):826\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1799_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1212\/WNL.0b013e31823efcf8","volume":"78","author":"GL Birbeck","year":"2012","unstructured":"Birbeck GL, et al. Evidence-based guideline: Antiepileptic drug selection for people with HIV\/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology. 2012;78(2):139\u201345.","journal-title":"Neurology"},{"issue":"5","key":"1799_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2176\/nmc.ra.2015-0344","volume":"56","author":"R Hanaya","year":"2016","unstructured":"Hanaya R, Arita K. The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications. Neurol Med Chir. 2016;56(5):205\u201320.","journal-title":"Neurol Med Chir"},{"key":"1799_CR27","unstructured":"World Health Organization, Geneva, Switzerland (2017) WHO model list of essential medicines. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/273826\/EML-20-eng.pdf?ua=1 on October 2nd, 2020."},{"key":"1799_CR28","unstructured":"P.N, P., Antiepileptic Drug Interactions; Lamotrigine. p. pp 55-60."},{"issue":"1","key":"1799_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","volume":"15","author":"AA Veroniki","year":"2017","unstructured":"Veroniki AA, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017;15(1):95.","journal-title":"BMC Med"},{"issue":"6","key":"1799_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","volume":"17","author":"T Tomson","year":"2018","unstructured":"Tomson T, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530\u20138.","journal-title":"Lancet Neurol"},{"issue":"7","key":"1799_CR31","doi-asserted-by":"publisher","first-page":"e017248","DOI":"10.1136\/bmjopen-2017-017248","volume":"7","author":"AA Veroniki","year":"2017","unstructured":"Veroniki AA, et al. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. BMJ Open. 2017;7(7):e017248.","journal-title":"BMJ Open"},{"issue":"2","key":"1799_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0378-3782(87)90039-9","volume":"15","author":"MR Holdiness","year":"1987","unstructured":"Holdiness MR. Teratology of the antituberculosis drugs. Early Hum Dev. 1987;15(2):61\u201374.","journal-title":"Early Hum Dev"},{"key":"1799_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.seizure.2019.08.016","volume":"71","author":"S Menon","year":"2019","unstructured":"Menon S, et al. Women with epilepsy in sub\u2013Saharan Africa: A review of the reproductive health challenges and perspectives for management. Seizure. 2019;71:312\u20137.","journal-title":"Seizure"},{"issue":"1","key":"1799_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"6","key":"1799_CR35","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.4269\/ajtmh.16-0107","volume":"96","author":"MA Elafros","year":"2017","unstructured":"Elafros MA, et al. Patient-Reported Adverse Effects Associated with Combination Antiretroviral Therapy and Coadministered Enzyme-Inducing Antiepileptic Drugs. Am J Trop Med Hyg. 2017;96(6):1505\u201311.","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"1799_CR36","doi-asserted-by":"publisher","first-page":"e0135501","DOI":"10.1371\/journal.pone.0135501","volume":"10","author":"L Knight","year":"2015","unstructured":"Knight L, et al. Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women. PLoS One. 2015;10(8):e0135501.","journal-title":"PLoS One"},{"issue":"5","key":"1799_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-4632.2012.05743.x","volume":"52","author":"B Saka","year":"2013","unstructured":"Saka B, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Int J Dermatol. 2013;52(5):575\u20139.","journal-title":"Int J Dermatol"},{"issue":"2","key":"1799_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40801-017-0105-x","volume":"4","author":"K Irungu","year":"2017","unstructured":"Irungu K, Nyamu D, Opanga S. Characterization of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Admitted to Kenyatta National Hospital: A Retrospective Cross-Sectional Study. Drugs - Real World Outcomes. 2017;4(2):79\u201385.","journal-title":"Drugs - Real World Outcomes"},{"issue":"9","key":"1799_CR39","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/qjmed\/hcs078","volume":"105","author":"SMH Kannenberg","year":"2012","unstructured":"Kannenberg SMH, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study. QJM. 2012;105(9):839\u201346.","journal-title":"QJM"},{"issue":"5","key":"1799_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.7196\/SAMJ.6077","volume":"103","author":"N Dube","year":"2013","unstructured":"Dube N, Adewusi E, Summers R. Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: The Medunsa National Pharmacovigilance Centre, 2007 - 2012. S Afr Med J. 2013;103(5):322.","journal-title":"S Afr Med J"},{"issue":"5","key":"1799_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1468-1293.2006.00386.x","volume":"7","author":"MC Marazzi","year":"2006","unstructured":"Marazzi MC, et al. Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women. HIV Med. 2006;7(5):338\u201344.","journal-title":"HIV Med"},{"issue":"9","key":"1799_CR42","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1016\/S2214-109X(18)30275-4","volume":"6","author":"JJ Noubiap","year":"2018","unstructured":"Noubiap JJ, et al. Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis. Lancet Glob Health. 2018;6(9):e998\u2013e1007.","journal-title":"Lancet Glob Health"},{"key":"1799_CR43","first-page":"45","volume":"2010","author":"LO Omo-Aghoja","year":"2010","unstructured":"Omo-Aghoja LO, A.E, Omo-Aghoja VW, Onowhakpor A, Feyi-Waboso P. Is pregnancy associated with biochemical and haematological changes in HIV-infected Nigerian women? S Afr J Hiv Med. 2010;2010:45\u20138.","journal-title":"S Afr J Hiv Med"},{"issue":"1","key":"1799_CR44","doi-asserted-by":"publisher","first-page":"971","DOI":"10.4102\/sajhivmed.v20i1.971","volume":"20","author":"UC Mehta","year":"2019","unstructured":"Mehta UC, et al. Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa. South Afr J HIV Med. 2019;20(1):971.","journal-title":"South Afr J HIV Med"},{"issue":"15","key":"1799_CR45","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1097\/QAD.0000000000000394","volume":"28","author":"KC Liu","year":"2014","unstructured":"Liu KC, et al. Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia. AIDS (London, England). 2014;28(15):2259\u201368.","journal-title":"AIDS (London, England)"},{"issue":"9","key":"1799_CR46","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJMc1908155","volume":"381","author":"MM Raesima","year":"2019","unstructured":"Raesima MM, et al. Dolutegravir Use at Conception - Additional Surveillance Data from Botswana. N Engl J Med. 2019;381(9):885\u20137.","journal-title":"N Engl J Med"},{"issue":"9","key":"1799_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJMoa1905230","volume":"381","author":"R Zash","year":"2019","unstructured":"Zash R, et al. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana. N Engl J Med. 2019;381(9):827\u201340.","journal-title":"N Engl J Med"},{"issue":"2","key":"1799_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/QAI.0b013e3181ff04e6","volume":"56","author":"DK Ekouevi","year":"2011","unstructured":"Ekouevi DK, et al. Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, C\u00f4te d'Ivoire. J Acquir Immune Defic Syndr (1999). 2011;56(2):183\u20137.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"5","key":"1799_CR49","doi-asserted-by":"publisher","first-page":"e1001217","DOI":"10.1371\/journal.pmed.1001217","volume":"9","author":"DM Gibb","year":"2012","unstructured":"Gibb DM, et al. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. PLoS Med. 2012;9(5):e1001217.","journal-title":"PLoS Med"},{"issue":"10","key":"1799_CR50","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/QAD.0b013e32833a2a14","volume":"24","author":"N Ford","year":"2010","unstructured":"Ford N, et al. Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts. Aids. 2010;24(10):1461\u201370.","journal-title":"Aids"},{"issue":"6","key":"1799_CR51","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.4103\/1319-2442.275462","volume":"30","author":"H Baynes","year":"2019","unstructured":"Baynes H, et al. Chronic kidney disease among human immunodeficiency virus positive patients on antiretroviral therapy in sub-Saharan Africa: A systematic review and meta-analysis. Saudi J Kidney Dis Transplant. 2019;30(6):1190.","journal-title":"Saudi J Kidney Dis Transplant"},{"issue":"1","key":"1799_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12981-019-0227-1","volume":"16","author":"TJ Mtisi","year":"2019","unstructured":"Mtisi TJ, et al. Tenofovir-associated kidney disease in Africans: a systematic review. AIDS Res Ther. 2019;16(1):12.","journal-title":"AIDS Res Ther"},{"issue":"8","key":"1799_CR53","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/INF.0000000000002332","volume":"38","author":"AR Cassidy","year":"2019","unstructured":"Cassidy AR, et al. In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana. Pediatr Infect Dis J. 2019;38(8):828\u201334.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"1799_CR54","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/QAD.0000000000001790","volume":"32","author":"S Chaudhury","year":"2018","unstructured":"Chaudhury S, et al. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana. AIDS (London, England). 2018;32(9):1173\u201383.","journal-title":"AIDS (London, England)"},{"issue":"4","key":"1799_CR55","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-0988","volume":"140","author":"S Chaudhury","year":"2017","unstructured":"Chaudhury S, et al. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months. Pediatrics. 2017;140(4):e20170988.","journal-title":"Pediatrics"},{"issue":"11","key":"1799_CR56","first-page":"803","volume":"3","author":"CJ Wedderburn","year":"2019","unstructured":"Wedderburn CJ, et al. Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study. The Lancet. Child Adolesc Health. 2019;3(11):803\u201313.","journal-title":"Child Adolesc Health"},{"issue":"3","key":"1799_CR57","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1097\/QAI.0000000000001799","volume":"79","author":"D Kacanek","year":"2018","unstructured":"Kacanek D, et al. Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana. J Acquir Immune Defic Syndr (1999). 2018;79(3):e93\u2013e100.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"1799_CR58","doi-asserted-by":"crossref","unstructured":"Neligan A, Shorvon SD. Frequency and Prognosis of Convulsive Status Epilepticus of Different Causes. Arch Neurol. 2010;67(8).","DOI":"10.1001\/archneurol.2010.169"},{"issue":"18","key":"1799_CR59","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1212\/WNL.0000000000001542","volume":"84","author":"SM Kariuki","year":"2015","unstructured":"Kariuki SM, et al. Prevalence and factors associated with convulsive status epilepticus in Africans with epilepsy. Neurology. 2015;84(18):1838\u201345.","journal-title":"Neurology"},{"key":"1799_CR60","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.yebeh.2017.07.002","volume":"76","author":"KR Rajiv","year":"2017","unstructured":"Rajiv KR, Radhakrishnan A. Status epilepticus in pregnancy: Etiology, management, and clinical outcomes. Epilepsy Behav. 2017;76:114\u20139.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"1799_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093543","volume":"9","author":"L Knight","year":"2014","unstructured":"Knight L, et al. Factors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysis. PLoS One. 2014;9(4):e93543.","journal-title":"PLoS One"},{"issue":"6","key":"1799_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5698\/1535-7511-11.6.189","volume":"11","author":"BE Gidal","year":"2011","unstructured":"Gidal BE. Carbamazepine hypersensitivity: progress toward predicting the unpredictable. Epilepsy Curr. 2011;11(6):189\u201391.","journal-title":"Epilepsy Curr"},{"key":"1799_CR63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.seizure.2014.12.001","volume":"25","author":"X-q Wang","year":"2015","unstructured":"Wang X-q, et al. Risk of a lamotrigine-related skin rash: Current meta-analysis and postmarketing cohort analysis. Seizure. 2015;25:52\u201361.","journal-title":"Seizure"},{"key":"1799_CR64","doi-asserted-by":"crossref","unstructured":"Sharma AN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review. Int J Womens Derm. 2020.","DOI":"10.1016\/j.ijwd.2020.04.002"},{"issue":"6982","key":"1799_CR65","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"W-H Chung","year":"2004","unstructured":"Chung W-H, et al. A marker for Stevens\u2013Johnson syndrome. Nature. 2004;428(6982):486.","journal-title":"Nature"},{"issue":"6","key":"1799_CR66","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/clpt.2012.189","volume":"92","author":"VL Yip","year":"2012","unstructured":"Yip VL, et al. HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review. Clin Pharm Ther. 2012;92(6):757\u201365.","journal-title":"Clin Pharm Ther"},{"key":"1799_CR67","first-page":"3186328","volume":"2017","author":"WL Fan","year":"2017","unstructured":"Fan WL, et al. HLA Association with Drug-Induced Adverse Reactions. J Immunol Res. 2017;2017:3186328.","journal-title":"J Immunol Res"},{"issue":"4","key":"1799_CR68","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1258\/om.2011.110003","volume":"4","author":"\u00c4 Bartels","year":"2011","unstructured":"Bartels \u00c4, O'Donoghue K. Cholesterol in pregnancy: a review of knowns and unknowns. Obstet Med. 2011;4(4):147\u201351.","journal-title":"Obstet Med"},{"issue":"4","key":"1799_CR69","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1542\/peds.2006-1939","volume":"120","author":"RJ Edison","year":"2007","unstructured":"Edison RJ, et al. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics. 2007;120(4):723\u201333.","journal-title":"Pediatrics"},{"issue":"4","key":"1799_CR70","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4314\/ahs.v14i4.28","volume":"14","author":"AO Maymunah","year":"2014","unstructured":"Maymunah AO, et al. Hypercholesterolaemia in pregnancy as a predictor of adverse pregnancy outcome. Afr Health Sci. 2014;14(4):967\u201373.","journal-title":"Afr Health Sci"},{"issue":"1","key":"1799_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.diabet.2006.07.002","volume":"33","author":"JM Gonz\u00e1lez-Clemente","year":"2007","unstructured":"Gonz\u00e1lez-Clemente JM, et al. Increased cholesterol intake in women with gestational diabetes mellitus. Diabetes Metab. 2007;33(1):25\u20139.","journal-title":"Diabetes Metab"},{"issue":"5","key":"1799_CR72","doi-asserted-by":"crossref","first-page":"491","DOI":"10.33549\/physiolres.930813","volume":"55","author":"C Qiu","year":"2006","unstructured":"Qiu C, et al. Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia. Physiol Res. 2006;55(5):491\u2013500.","journal-title":"Physiol Res"},{"issue":"4","key":"1799_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/09513590500154019","volume":"21","author":"SE Sanchez","year":"2005","unstructured":"Sanchez SE, et al. A case-control study of oxidized low density lipoproteins and preeclampsia risk. Gynecol Endocrinol. 2005;21(4):193\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1799_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-1211(00)00119-4","volume":"41","author":"J Eir\u0131\u0301s","year":"2000","unstructured":"Eir\u0131\u0301s J, et al. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res. 2000;41(1):1\u20137.","journal-title":"Epilepsy Res"},{"issue":"1","key":"1799_CR75","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/08830738060210011601","volume":"21","author":"M Castro-Gago","year":"2006","unstructured":"Castro-Gago M, et al. Evolution of Serum Lipids and Lipoprotein (a) Levels in Epileptic Children Treated With Carbamazepine, Valproic Acid, and Phenobarbital. J Child Neurol. 2006;21(1):48\u201353.","journal-title":"J Child Neurol"},{"issue":"3","key":"1799_CR76","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1440-1754.1997.tb01588.x","volume":"33","author":"A Verrotti","year":"1997","unstructured":"Verrotti A, et al. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J Paediatr Child Health. 1997;33(3):242\u20135.","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"1799_CR77","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0887-8994(98)00084-8","volume":"19","author":"A Verrotti","year":"1998","unstructured":"Verrotti A, et al. Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol. 1998;19(5):364\u20137.","journal-title":"Pediatr Neurol"},{"issue":"2-3","key":"1799_CR78","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.eplepsyres.2006.05.002","volume":"70","author":"KA Voudris","year":"2006","unstructured":"Voudris KA, et al. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy. Epilepsy Res. 2006;70(2-3):211\u20137.","journal-title":"Epilepsy Res"},{"key":"1799_CR79","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874192401105010049","volume":"5","author":"ER Feeney","year":"2011","unstructured":"Feeney ER, Mallon PWG. HIV and HAART-Associated Dyslipidemia. Open Cardiovasc Med J. 2011;5:49\u201363.","journal-title":"Open Cardiovasc Med J"},{"issue":"6","key":"1799_CR80","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1093\/ije\/dyw312","volume":"45","author":"DG Dillon","year":"2016","unstructured":"Dillon DG, et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol. 2016;45(6):2210\u20131.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"1799_CR81","doi-asserted-by":"publisher","first-page":"e0201404","DOI":"10.1371\/journal.pone.0201404","volume":"13","author":"CA Dimala","year":"2018","unstructured":"Dimala CA, Blencowe H, Choukem SP. The association between antiretroviral therapy and selected cardiovascular disease risk factors in sub-Saharan Africa: A systematic review and meta-analysis. PLoS One. 2018;13(7):e0201404.","journal-title":"PLoS One"},{"issue":"1","key":"1799_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2581-8","volume":"17","author":"MJ Harmsen","year":"2017","unstructured":"Harmsen MJ, et al. The association between HIV (treatment), pregnancy serum lipid concentrations and pregnancy outcomes: a systematic review. BMC Infect Dis. 2017;17(1):489.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1799_CR83","doi-asserted-by":"publisher","first-page":"e0198447","DOI":"10.1371\/journal.pone.0198447","volume":"13","author":"AA Veroniki","year":"2018","unstructured":"Veroniki AA, et al. Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs. PLoS One. 2018;13(6):e0198447.","journal-title":"PLoS One"},{"issue":"1","key":"1799_CR84","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jamapediatrics.2014.1889","volume":"169","author":"PL Williams","year":"2015","unstructured":"Williams PL, et al. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants. JAMA Pediatr. 2015;169(1):48\u201355.","journal-title":"JAMA Pediatr"},{"key":"1799_CR85","unstructured":"Human Genetics Policy Guidelines for the Management and Prevention of Genetic Disorders, B.D.a.D.P., South Africa: Sub-Directorate, Human Genetics, National Department of Health 2008: p. www.doh.gov.za Accessed on line on 21 Mar 2020."},{"key":"1799_CR86","unstructured":"AIDSmap, Efavirenz does not increase the risk of suicidal thoughts or depression in Ugandan adults. 2018."},{"issue":"4","key":"1799_CR87","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/sdi.12385","volume":"28","author":"AD Bansal","year":"2015","unstructured":"Bansal AD, Hill CE, Berns JS. Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease. Semin Dial. 2015;28(4):404\u201312.","journal-title":"Semin Dial"},{"key":"1799_CR88","unstructured":"G.A, M. Clinical Challenges in Therapeutic Drug Monitoring; Special Populations, Physiological Conditions and Pharmacogenomics: Elsevier Sciencedirect; 2016. p. 101\u201334."},{"issue":"7637","key":"1799_CR89","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/bmj.39406.652986.BE","volume":"336","author":"D Williams","year":"2008","unstructured":"Williams D, Davison J. Chronic kidney disease in pregnancy. BMJ. 2008;336(7637):211\u20135.","journal-title":"BMJ"},{"issue":"1","key":"1799_CR90","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/01.mnh.0000436545.94132.52","volume":"23","author":"W Hussein","year":"2014","unstructured":"Hussein W, Lafayette RA. Renal function in normal and disordered pregnancy. Curr Opin Nephrol Hypertens. 2014;23(1):46\u201353.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7 Suppl 1","key":"1799_CR91","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5414\/CNP83S032","volume":"83","author":"S Naicker","year":"2015","unstructured":"Naicker S, Rahmanian S, Kopp JB. HIV and chronic kidney disease. Clin Nephrol. 2015;83(7 Suppl 1):32\u20138.","journal-title":"Clin Nephrol"},{"issue":"1","key":"1799_CR92","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2352-3018(15)00211-8","volume":"3","author":"A Mocroft","year":"2016","unstructured":"Mocroft A, et al. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. Lancet HIV. 2016;3(1):e23\u201332.","journal-title":"Lancet HIV"},{"issue":"12","key":"1799_CR93","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/jix542","volume":"216","author":"J Pintye","year":"2017","unstructured":"Pintye J, et al. Maternal Tenofovir Disoproxil Fumarate Use During Pregnancy Is Not Associated With Adverse Perinatal Outcomes Among HIV-infected East African Women: A Prospective Study. J Infect Dis. 2017;216(12):1561\u20138.","journal-title":"J Infect Dis"},{"key":"1799_CR94","unstructured":"World Health Organization Geneva, Switzerland (2013); Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. https:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/ accessed online 2 Oct 2020."},{"issue":"3","key":"1799_CR95","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/ckj\/sfv016","volume":"8","author":"G Manisco","year":"2015","unstructured":"Manisco G, et al. Pregnancy in end-stage renal disease patients on dialysis: how to achieve a successful delivery. Clin Kidney J. 2015;8(3):293\u20139.","journal-title":"Clin Kidney J"},{"issue":"4","key":"1799_CR96","doi-asserted-by":"publisher","first-page":"ofx187","DOI":"10.1093\/ofid\/ofx187","volume":"4","author":"V Ramokolo","year":"2017","unstructured":"Ramokolo V, et al. In Utero ART Exposure and Birth and Early Growth Outcomes Among HIV-Exposed Uninfected Infants Attending Immunization Services: Results From National PMTCT Surveillance, South Africa. Open Forum Infect Dis. 2017;4(4):ofx187.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"1799_CR97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yebeh.2013.06.026","volume":"29","author":"TL Reisinger","year":"2013","unstructured":"Reisinger TL, et al. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav. 2013;29(1):13\u20138.","journal-title":"Epilepsy Behav"},{"issue":"10","key":"1799_CR98","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1586\/14737175.2015.1083422","volume":"15","author":"PE Voinescu","year":"2015","unstructured":"Voinescu PE, Pennell PB. Management of epilepsy during pregnancy. Expert Rev Neurother. 2015;15(10):1171\u201387.","journal-title":"Expert Rev Neurother"},{"key":"1799_CR99","doi-asserted-by":"crossref","unstructured":"Antiepileptic drugs: the drawbacks of generic substitution. Lancet Neurol. 2010;9(3):227.","DOI":"10.1016\/S1474-4422(10)70044-2"},{"issue":"3","key":"1799_CR100","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4103\/0970-0358.90824","volume":"44","author":"IO Fadeyibi","year":"2011","unstructured":"Fadeyibi IO, et al. Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study. Indian J Plast Surg. 2011;44(3):467\u201373.","journal-title":"Indian J Plast Surg"},{"key":"1799_CR101","unstructured":"Bittencourt PR, S.J, Mazer S Meinardi H, editor, Viral, bacterial, fungal and parasitic infections associated with seizure disorders. Elsevier Sciences; , 1999. Handbook of Clinical Neurology. Vol. 72. Amsterdam: 1999. The Epilepsies: p. pp. 145\u2013174."},{"key":"1799_CR102","unstructured":"OH DB. In: Engel JJ, Pedley TA, editors. Infections and inflammatory diseases: Lippincott Williams & Wilkins; 2008. p. 2643\u201352. 2(Epilepsy)."},{"issue":"2","key":"1799_CR103","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5698\/1535-7511-12.2.63","volume":"12","author":"PB Pennell","year":"2012","unstructured":"Pennell PB. Too Complicated or So Simple: AED Type and AED Dose Matter for Pregnancy. Epilepsy Curr. 2012;12(2):63\u20135.","journal-title":"Epilepsy Curr"},{"issue":"2","key":"1799_CR104","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","volume":"77","author":"J Morrow","year":"2006","unstructured":"Morrow J, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 2006;77(2):193\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1799_CR105","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11904-015-0273-9","volume":"12","author":"AR Eckard","year":"2015","unstructured":"Eckard AR, McComsey GA. The role of statins in the setting of HIV infection. Curr HIV\/AIDS Rep. 2015;12(3):305\u201312.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"1799_CR106","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","volume":"10","author":"DG Karalis","year":"2016","unstructured":"Karalis DG, et al. The risks of statin use in pregnancy: A systematic review. J Clin Lipidol. 2016;10(5):1081\u201390.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"1799_CR107","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/QAD.0000000000001313","volume":"31","author":"LM Mofenson","year":"2017","unstructured":"Mofenson LM, Baggaley RC, Mameletzis I. Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding. AIDS. 2017;31(2):213\u201332.","journal-title":"AIDS"},{"issue":"11","key":"1799_CR108","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1093\/jac\/dkt246","volume":"68","author":"Q Fillekes","year":"2013","unstructured":"Fillekes Q, et al. Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trial. J Antimicrob Chemother. 2013;68(11):2609\u201315.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1799_CR109","doi-asserted-by":"publisher","first-page":"e1000430","DOI":"10.1371\/journal.pmed.1000430","volume":"8","author":"C Zeh","year":"2011","unstructured":"Zeh C, et al. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis. PLoS Med. 2011;8(3):e1000430.","journal-title":"PLoS Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01799-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-020-01799-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01799-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T10:11:13Z","timestamp":1669630273000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01799-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1799"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01799-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}